Hemogenyx Pharmaceuticals
Created in 2013
- BETA
Trend leader (A+)
Existing signals make this entity one of the most dynamic startups Social networks
416Activities
Entity types
Location
1361 Amsterdam Ave # 320, New York, NY 10027, USA
New York
United States of America
Employees
Scale: 11-50
Estimated: 8
Engaged corporates
1
0 0Added in Motherbase
8 months ago
biotech Value proposition
Hemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located in New York City at its state-of-the-art research facility.
The Company is a clinical-stage biopharmaceutical group developing new medicines and treatments for life-threatening diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.
Hemogenyx Pharmaceuticals – Breakthrough therapies for the treatment of blood diseases and viral infections
https://hemogenyx.com/
